New molecule could reverse neurodegeneration in Parkinson’s

News

Author: Simge Eva DoganPublished: 11 October 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

molecule

Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.

The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.

The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.

They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.

Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


Parkinson's neurology deep brain stimulation

sponsored article

Advances

Deep brain stimulation: the future is personalised

Two experts on how “dual targeting” is changing DBS treatment for Parki

READ MORE
Vital nutrition Parkinson's recipe

Recipes & Nutrition

Nutrition-packed summer recipe for people with Parkinson’s

Nutritional therapist shares a two-course recipe

READ MORE

Global update

‘No Time Like the Future’: Michael J Fox announces new book

The fourth book by the US actor and Parkinson’s campaigner

READ MORE